CoChat

Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration

Open access

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Abstract

Activation of innate immunity and deposition of blood-derived fibrin in the central nervous system (CNS) occur in autoimmune and neurodegenerative diseases, including multiple sclerosis (MS) and Alzheimer's disease (AD). However, the mechanisms that link disruption of the blood-brain barrier (BBB) to neurodegeneration are poorly understood, and exploration of fibrin as a therapeutic target has been limited by its beneficial clotting functions. Here we report the generation of monoclonal antibody 5B8, targeted against the cryptic fibrin epitope γ 377-395, to selectively inhibit fibrin-induced inflammation and oxidative stress without interfering with clotting. 5B8 suppressed fibrin-induced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation and the expression of proinflammatory genes. In animal models of MS and AD, 5B8 entered the CNS and bound to parenchymal fibrin, and its therapeutic administration reduced the activation of innate immunity and neurodegeneration. Thus, fibrin-targeting immunotherapy inhibited autoimmunity- and amyloid-driven neurotoxicity and might have clinical benefit without globally suppressing innate immunity or interfering with coagulation in diverse neurological diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41590-018-0232-x

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Research works printed but not linked: 1

  1. Davalos D Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun 3, 1227 (2012). 23187627 PMC3514498

Cited by

See all 214

Metadata

Authors
Ryu, J. K., Rafalski, V. A., Meyer-Franke, A., Adams, R. A., Poda, S. B., Rios Coronado, P. E., Pedersen, L. Ø., Menon, V., Baeten, K. M., Sikorski, S. L., Bedard, C., Hanspers, K., Bardehle, S., Mendiola, A. S., Davalos, D., Machado, M. R., Chan, J. P., Plastira, I., Petersen, M. A., Pfaff, S. J., Ang, K. K., Hallenbeck, K. K., Syme, C., Hakozaki, H., Ellisman, M. H., Swanson, R. A., Zamvil, S. S., Arkin, M. R., Zorn, S. H., Pico, A. R., Mucke, L., Freedman, S. B., Stavenhagen, J. B., Nelson, R. B., & Akassoglou, K.
Affiliations
  • Gladstone Institutes (US)
  • University of California San Diego (US)
  • Lundbeck (Denmark) (DK)
  • Cleveland Clinic (US)
  • University of California, San Francisco (US)
  • San Francisco VA Medical Center (US)
Corresponding author
Akassoglou, Katerina
Venue
Nature Immunology
Published
2018-10-15
Volume
19
Issue
11
Pages
1212-1223
ISSN
  • 1529-2908 (ISSN-L)
  • 1529-2916
OpenAlex
W2896105679
Cited by
213
References
67
Citations by year
2026: 21 · 2025: 21 · 2024: 37 · 2023: 25 · 2022: 29 · 2021: 36 · 2020: 21 · 2019: 20 · 2018: 3
FWCI
8.97
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Science Foundation (0648991, 1144247)
  • National Multiple Sclerosis Society (RG1701‐26628, FG-1708-28925)
  • Conrad N. Hilton Foundation (17348)
  • American Heart Association
  • S. D. Bechtel, Jr. Foundation and Stephen Bechtel Fund
  • Gladstone Institutes (RR18928)
  • Multiple Sclerosis Society
  • H. Lundbeck A/S
  • National Institutes of Health (5k12hd072222-05, 1c06rr018928-01, CA082103, P41 GM10341)
  • University of California, San Francisco
  • National Cancer Institute (P30CA082103)
  • National Institute of General Medical Sciences (T32GM007175)
  • National Institute of Allergy and Infectious Diseases (T32AI007334)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK090382)
  • National Institute of Neurological Disorders and Stroke (R01NS081149, NS082976, NS096920, NS052189, R21NS082976, R21NS108159, R35NS097976, R01NS052189, F32NS096920, NS097976, R01NS092835, NS081149)
  • National Center for Research Resources (C06-RR-018928, RR18928)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12-HD072222, P01HD084387)
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
neuroinflammation, neurodegeneration, multiple sclerosis, Alzheimer's disease, blood-brain barrier disruption, innate immunity, NADPH oxidase, oxidative stress, fibrin deposition, coagulation
MeSH terms
Animals, Antibodies, Monoclonal, Epitopes, Fibrinogen, Humans, Inflammation, Neurodegenerative Diseases, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration. https://app.cochat.ai/papers/10.1038/s41590-018-0232-x
The paper
Ryu, J. K., Rafalski, V. A., Meyer-Franke, A., Adams, R. A., Poda, S. B., Rios Coronado, P. E., Pedersen, L. Ø., Menon, V., Baeten, K. M., Sikorski, S. L., Bedard, C., Hanspers, K., Bardehle, S., Mendiola, A. S., Davalos, D., Machado, M. R., Chan, J. P., Plastira, I., Petersen, M. A., . . . Akassoglou, K. (2018). Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration. Nature Immunology. https://doi.org/10.1038/s41590-018-0232-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.